Ondine Biomedical Inc. NPV (CDI) (OBI)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

13.72p
   
  • Change Today:
      0.97p
  • 52 Week High: 14.50p
  • 52 Week Low: 5.63p
  • Currency: UK Pounds
  • Shares Issued: 444.23m
  • Volume: 206,594
  • Market Cap: £60.96m
  • Beta: 0.01

OBI Overview

Ondine Biomedical Inc. is a life sciences company, incorporated in Canada, focusing on the development of photodisinfection-based therapies to provide solutions to drug-resistant infections. Ondine has created a platform technology called antimicrobial photodynamic disinfection, or "photodisinfection", to help prevent and help treat infections across different therapeutic areas in healthcare and industry settings.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1230.7% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 63.3 n/a
Pr/Book 36.5  
Latest F'cast
Revenue 88.6% n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

OBI Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 1.79 (16.27) (23.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 2.57 (50.08) (63.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-22 0.64 (19.37) (10.00)¢ n/a n/a n/a n/a 0.0%
31-Dec-23 1.20 (14.41) (7.00)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

OBI Company Announcements

Share Issuance for ICU Study Enrollment Completion 22-Jul-2025 17:38 RNS
Steriwave ICU Study Completes Recruitment 21-Jul-2025 07:00 RNS
Ondine Appoints Peel Hunt as Broker 01-Jul-2025 07:00 RNS

OBI ShareCast News

Ondine completes landmark Steriwave study 21-Jul-2025 ShareCast
Ondine Biomedical upbeat on new Steriwave test d... 09-Jun-2025 ShareCast
Ondine's Steriwave adopted by Ottawa Heart Insti... 05-Jun-2025 ShareCast

Latest OBI Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

OBI Market Data

Currency UK Pounds
Share Price 13.72p
Change Today 0.97p
% Change 7.63 %
52 Week High 14.50p
52 Week Low 5.63p
Volume 206,594
Shares Issued 444.23m
Market Cap £60.96m
Beta 0.01

OBI Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
70.03% below the market average70.03% below the market average70.03% below the market average70.03% below the market average70.03% below the market average
95.35% below the sector average95.35% below the sector average95.35% below the sector average95.35% below the sector average95.35% below the sector average
Price Trend
10.87% above the market average10.87% above the market average10.87% above the market average10.87% above the market average10.87% above the market average
64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average64.44% above the sector average
Income Not Available
Growth
41.69% above the market average41.69% above the market average41.69% above the market average41.69% above the market average41.69% above the market average
53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average53.33% above the sector average

OBI Dividends

No dividends found

Trades for 11-Aug-2025

Time Volume / Share Price
09:42 714 @ 14.00p
08:31 74,044 @ 13.50p
08:12 60,606 @ 13.19p
09:01 10,000 @ 13.18p
08:33 20,000 @ 13.48p

OBI Key Personnel

Chair Jean Charest
CEO Carolyn Cross

Top of Page